Enquire Now

Product CAS No


Product Description

Baricitinib is a selective and reversible Janus kinase 1 (JAK1) and 2 (JAK2) inhibitor. Janus kinases belong to the tyrosine protein kinase family and play an important role in the proinflammatory pathway signalling that is frequently over-activated in autoimmune disorders such as rheumatoid arthritis.

Therapeutic Action

Baricitinib is used to treat rheumatoid arthritis.Baricitinib is being studied for use in combination with another drug (remdesivir) to treat coronavirus disease (COVID-19).The most common serious infections include pneumonia, shingles, and urinary tract infections.

Enquire Now
close slider